Tech Company Financing Transactions
JaxBio Technologies Funding Round
European Innovation Council Fund participated in a $2.7 million funding round for JaxBio Technologies. This venture round closed on 7/17/2024.
Transaction Overview
Company Name
Announced On
7/17/2024
Transaction Type
Debt
Amount
$2,700,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand clinical programs and develop its diagnostics platform to create a blood test for making lung cancer detection and management simpler, quicker, and highly accurate.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Poleg Complex, Sderot Gibori Israel 7
Netanya, Undisclosed
Israel
Netanya, Undisclosed
Israel
Phone
Undisclosed
Website
Email Address
Overview
JaxBio aims to change the way cancer is diagnosed and managed, with a simple and sensitive blood test. This test will enable early detection, monitoring of disease status, and predicting response to therapy. JaxBio develops a unique platform capable of probing thousands of cancer-specific biomarkers circulating in the blood, at high sensitivity and low cost.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shahar Zirkin
Chief Scientific Officer
Yuval Ebenstein
Chief Technical Officer
Yael Michaeli
Co-Founder
Joel Bar-El
Co-Founder
Dror Feldheim
VP - R & D
Noa Gilat
Browse more venture capital transactions:
Prev: 7/17/2024: Again venture capital transaction
Next: 7/17/2024: Indie Campers venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs